A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance

Review expert faculty discussion of BTK inhibitor resistance in CLL, including optimal testing and treatment sequencing to overcome resistance to prior therapy through a text module with accompanying slides, podcast, and ClinicalThought.

Share

Program Content

Activities

BTKi Resistance in CLL
A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 01, 2024

Expires: March 31, 2025

Activities

BTKi Resistance in CLL
Understanding BTK Inhibitor Resistance in CLL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 01, 2024

Expires: September 30, 2025

Activities

MRD and BTKi Resistance in CLL
CLL Management: Testing for MRD and BTK Mutations
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 05, 2024

Expires: November 04, 2025

Activities

Understanding BTK Inhibitor Resistance in CLL
A Cancer Conversation: Optimizing the Care of Patients With CLL Through a Deeper Understanding of BTK Inhibitor Resistance
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: October 01, 2024

Expires: September 30, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from AstraZeneca

AstraZeneca